Jammed Micro-Flake Hydrogel for Four-Dimensional Living Cell Bioprinting

© 2022 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 34(2022), 15 vom: 31. Apr., Seite e2109394
1. Verfasser: Ding, Aixiang (VerfasserIn)
Weitere Verfasser: Jeon, Oju, Cleveland, David, Gasvoda, Kaelyn L, Wells, Derrick, Lee, Sang Jin, Alsberg, Eben
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article bioinks cross-linking gradient four-dimensional printing shape morphing tissue engineering Hydrogels
Beschreibung
Zusammenfassung:© 2022 Wiley-VCH GmbH.
4D bioprinting is promising to build cell-laden constructs (bioconstructs) with complex geometries and functions for tissue/organ regeneration applications. The development of hydrogel-based 4D bioinks, especially those allowing living cell printing, with easy preparation, defined composition, and controlled physical properties is critically important for 4D bioprinting. Here, a single-component jammed micro-flake hydrogel (MFH) system with heterogeneous size distribution, which differs from the conventional granular microgel, has been developed as a new cell-laden bioink for 4D bioprinting. This jammed cytocompatible MFH features scalable production and straightforward composition with shear-thinning, shear-yielding, and rapid self-healing properties. As such, it can be smoothly printed into stable 3D bioconstructs, which can be further cross-linked to form a gradient in cross-linking density when a photoinitiator and a UV absorber are incorporated. After being subject to shape morphing, a variety of complex bioconstructs with well-defined configurations and high cell viability are obtained. Based on this system, 4D cartilage-like tissue formation is demonstrated as a proof-of-concept. The establishment of this versatile new 4D bioink system may open up a number of applications in tissue engineering
Beschreibung:Date Completed 15.04.2022
Date Revised 26.08.2024
published: Print-Electronic
ErratumIn: Adv Mater. 2024 Jan;36(2):e2312067. doi: 10.1002/adma.202312067. - PMID 38102086
Citation Status MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202109394